Disappointment over drug snub

A charity has expressed its "disappointment" over a decision not to provide a life-extending breast cancer drug on the NHS. The drug, known Perjeta, was trialled at The Christie specialist hospital in Manchester.

View all 2 updates ›

Breast cancer drug denied due to cost

Cancer charities have condemned a decision not to licence a drug being trialled in our region which extends the life of women suffering the advanced stages of breast cancer.

The National Institute for Clinical Excellence - or NICE - says the drug "Perjeeta" isn't cost effective.

Perjeeta is currently being tested on women through the Christie Hospital in Manchester - but it isn't routinely available on the NHS.

Cancer charities and women taking the drug want NICE to reconsider .

Ashley Derricott reports.

More top news